CompletedNCT00460239
Buprenorphine dose effects in people with opioid misuse
About this title
Read the official source — NCT00460239Medication studyAges 21–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 55 years.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJanuary 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 12
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT00460239
- Official title
Show the full official title
Evaluation of Opioid Antagonist Activity in Humans
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine, Morphine and Placebo.
Who was this study for?
Listed age limits: 21 years to 55 years.
